Jingyi Chen1, Jie Yan1, Chunfeng Wang1, Ying Wang1, Yong Wu2, Rong Hu3. 1. The School of Nursing, Fujian Medical University, No. 1 of Xueyuan Road, Shangjie Town, Minhou County, Fuzhou City, Fujian Province, China. 2. Department of Hematology, Fujian Medical University Union Hospital, No. 29 of Xinquan Road, Fuzhou City, Fujian Province, China. wuyong9195@126.com. 3. The School of Nursing, Fujian Medical University, No. 1 of Xueyuan Road, Shangjie Town, Minhou County, Fuzhou City, Fujian Province, China. ronghu1246@fjmu.edu.cn.
Abstract
PURPOSE: To evaluate potential effects and satisfaction of dignity therapy among patients with hematologic neoplasms in the Chinese cultural context. METHODS:Sixty-six patients with hematologic neoplasms were randomly assigned into either a dignity therapy group (N = 32) or control group (N = 34). The primary outcomes were level of hope and spiritual well-being, as measured according to the Herth Hope Index and the 12-item Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being, at baseline (T0), 1-week follow-up (T1), and 4-week follow-up (T2). Satisfaction with dignity therapy was assessed using a 5-grade marking system at T1. RESULTS: Among the 66 participants, 61 remained at 1-week follow-up and 57 remained at 4-week follow-up. Group differences were found in the total score and the scores of each dimension of spiritual well-being and level of hope at T1 and T2 (p < 0.05). Interaction effects were statistically significant in terms of spiritual well-being (p < 0.001) and level of hope (p < 0.001). Majority of the patients (93.34%) and family members (96.67%) gave positive evaluations ("very satisfactory" or "relatively satisfactory") for the dignity therapy intervention. CONCLUSION:Implementing dignity therapy among patients with hematologic neoplasms in China was associated with good efficacy in improving spiritual well-being and the level of hope in the short term. Difficulties and solutions involved in the implementation of dignity therapy in multiple cultures deserve attention.
RCT Entities:
PURPOSE: To evaluate potential effects and satisfaction of dignity therapy among patients with hematologic neoplasms in the Chinese cultural context. METHODS: Sixty-six patients with hematologic neoplasms were randomly assigned into either a dignity therapy group (N = 32) or control group (N = 34). The primary outcomes were level of hope and spiritual well-being, as measured according to the Herth Hope Index and the 12-item Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being, at baseline (T0), 1-week follow-up (T1), and 4-week follow-up (T2). Satisfaction with dignity therapy was assessed using a 5-grade marking system at T1. RESULTS: Among the 66 participants, 61 remained at 1-week follow-up and 57 remained at 4-week follow-up. Group differences were found in the total score and the scores of each dimension of spiritual well-being and level of hope at T1 and T2 (p < 0.05). Interaction effects were statistically significant in terms of spiritual well-being (p < 0.001) and level of hope (p < 0.001). Majority of the patients (93.34%) and family members (96.67%) gave positive evaluations ("very satisfactory" or "relatively satisfactory") for the dignity therapy intervention. CONCLUSION: Implementing dignity therapy among patients with hematologic neoplasms in China was associated with good efficacy in improving spiritual well-being and the level of hope in the short term. Difficulties and solutions involved in the implementation of dignity therapy in multiple cultures deserve attention.
Authors: Harvey Max Chochinov; Thomas Hack; Thomas Hassard; Linda J Kristjanson; Susan McClement; Mike Harlos Journal: J Clin Oncol Date: 2005-08-20 Impact factor: 44.544
Authors: Amy Sexauer; M Jennifer Cheng; Louise Knight; Anthony W Riley; Lauren King; Thomas J Smith Journal: J Palliat Med Date: 2014-01-02 Impact factor: 2.947
Authors: Annemieke Kuin; Luc Deliens; Lia van Zuylen; Annemie M Courtens; Myrra J F J Vernooij-Dassen; Barbara van der Linden; Gerrit van der Wal Journal: Palliat Med Date: 2006-09 Impact factor: 4.762
Authors: Michelle J Pearce; April D Coan; James E Herndon; Harold G Koenig; Amy P Abernethy Journal: Support Care Cancer Date: 2011-11-29 Impact factor: 3.603
Authors: Mounica Vallurupalli; Katharine Lauderdale; Michael J Balboni; Andrea C Phelps; Susan D Block; Andrea K Ng; Lisa A Kachnic; Tyler J Vanderweele; Tracy A Balboni Journal: J Support Oncol Date: 2011-11-16